Page 1066 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 13

369. Bodey GP, Anaissie EJ. Chronic systemic candidiasis. Eur J Clin 386. Pestalozzi BC, Krestin GP, Schanz U, Jacky E, GmÅr J. Hepatic
Microbiol Infect Dis. 1989;8(10):855-857. lesions of chronic disseminated candidiasis may become invis-
370. Jones JM. Granulomatous hepatitis due to Candida albicans in ible during neutropenia. Blood. 1997;90(10):3858-3864.
patients with acute leukemia. Ann Intern Med. 1981;94(4, pt 1): 387. Freifeld A, Bow EJ, Sepkowitz KA, et al. Clinical practice guide-
475-477. line for the use of antimicrobial agents in neutropenic patients
371. Tashjian LS, Abramson JS, Peacock JE Jr. Focal hepatic candi- with cancer: 2010 update by the infectious diseases society of
diasis: a distinct clinical variant of candidiasis in immunocom- america. Clin infect Dis. February 15, 2011;52(4):e46-e93.
promised patients. Rev Infect Dis. 1984;6(5):689-703. 388. Cordonnier C, Pautas C, Maury S, et al. Empirical versus pre-
372. Haron E, Feld R, Tuffnell P, Patterson B, Hasselback R, emptive antifungal therapy for high-risk, febrile, neutropenic
Matlow A. Hepatic candidiasis: an increasing problem in patients: a randomized, controlled trial. Clin Infect Dis. April 15,
immunocompromised patients. Am J Med. 1987;83(1):17-26. 2009;48(8):1042-1051.
373. Thaler M, Pastakia B, Shawker TH, O’Leary T, Pizzo PA. 389. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole
Hepatic candidiasis in cancer patients: the evolving picture of prophylaxis of fungal infections in patients with acute leukemia.
the syndrome. Ann Intern Med. 1988;108(1):88-100. Results of a randomized placebo-controlled, double-blind, mul-
ticenter trial. Ann Intern Med. 1993;118(7):495-503.
374. Woolley I, Curtis D, Szer J, et al. High dose cytosine arabinoside
is a major risk factor for the development of hepatosplenic 390. Schaffner A, Schaffner M. Effect of prophylactic fluconazole
candidiasis in patients with leukemia. Leuk Lymphoma. on the frequency of fungal infections, amphotericin B use, and
1997;27(5-6):469-474. health care costs in patients undergoing intensive chemotherapy
for hematologic neoplasias. J Infect Dis. 1995;172(4):1035-1041.
375. Antilla VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P.
Hepatosplenic candidiasis in patients with acute leukemia: 391. O’Hanley P, Easaw J, Rugo H, Easaw S. Infectious disease man-
incidence and prognostic implications. Clin Infect Dis. 1997;24: agement of adult leukemic patients undergoing chemotherapy:
375-380. 1982 to 1986 experience at Stanford University Hospital. Am J
Med. 1989;87(6):605-613.
376. Bjerke JW, Meyers JD, Bowden RA. Hepatosplenic
candidiasis—a contraindication to marrow transplantation? 392. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled
Blood. 1994;84(8):2811-2814. trial of fluconazole to prevent fungal infections in patients
undergoing bone marrow transplantation. N Engl J Med.
377. Sallah S. Hepatosplenic candidiasis in patients with acute leu-
kemia: increasingly encountered complication. Anticancer Res. 1992;326(13):845-851.
1999;19(1B):757-760. 393. Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of
fluconazole prophylaxis for fungal infections after marrow
378. Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P.
Hepatosplenic candidiasis in patients with acute leukaemia. Br J transplantation–a prospective, randomized, double-blind study.
Haematol. 1999;106(3):697-701. J Infect Dis. 1995;171(6):1545-1552.
379. Rossetti F, Brawner DL, Bowden R, et al. Fungal liver infection 394. Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intrave-
in marrow transplant recipients: prevalence at autopsy, predis- nous amphotericin B in neutropenic autologous bone marrow
posing factors, and clinical features. Clinical infectious diseases: transplant recipients. J Infect Dis. 1992;165(5):891-897.
An Official Publication of the Infectious Diseases Society of 395. Riley DK, Pavia AT, Beatty PG, et al. The prophylactic use of
America. April 1995;20(4):801-811. low-dose amphotericin B in bone marrow transplant patients.
380. Chen CY, Chen YC, Tang JL, et al. Hepatosplenic fungal infec- Am J Med. 1994;97(6):509-514.
tion in patients with acute leukemia in Taiwan: incidence, treat- 396. Anaissie EJ, Rex JH, Uzun O, Vartivarian S. Predictors of
ment, and prognosis 14. Ann Hematol. 2003;82(2):93-97. adverse outcome in cancer patients with candidemia. Am J Med.
381. Sallah S, Semelka R, Kelekis N, Worawattanakul S, Sallah W. 1998;104(3):238-245.
Diagnosis and monitoring response to treatment of hepa- 397. Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter
tosplenic candidiasis in patients with acute leukemia using exchanges and the duration of candidemia. Clin Infect Dis.
magnetic resonance imaging. Acta Haematol. 1998;100(2): 1995;21:994-996.
77-81. 398. Pappas PG, Rotstein CM, Betts RF, et al. Micafungin ver-
382. Semelka RC, Shoenut JP, Greenberg HM, Bow EJ. Detection of sus caspofungin for treatment of candidemia and other
acute and treated lesions of hepatosplenic candidiasis: compari- forms of invasive candidiasis. Clin Infect Dis. October 1,
son of dynamic contrast-enhanced CT and MR imaging. J Magn 2007;45(7):883-893.
Reson Imaging. 1992;2(3):341-345. 399. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E.
383. Mahgerefteh SY, Sosna J, Bogot N, Shapira MY, Pappo O, Bloom Infections due to emerging and uncommon medically
AI. Radiologic imaging and intervention for gastrointestinal important fungal pathogens. Clin Microbiol Infect. 2004;10
and hepatic complications of hematopoietic stem cell transplan- (suppl 1):48-66.
tation. Radiology. March 2011;258(3):660-671. 400. Tortorano AM, Dho G, Prigitano A, et al. Invasive fungal
384. Anttila VJ, Ruutu P, Bondestam S, et al. Hepatosplenic yeast infections in the intensive care unit: a multicentre, prospec-
infection in patients with acute leukemia: a diagnostic problem. tive, observational study in Italy (2006-2008). Mycoses. January
Clin Infect Dis. 1994;18(6):979-981. 2012;55(1):73-79.
385. von Eiff M, Essink M, Roos N, Hiddemann W, Buchner T, 401. Khasawneh F, Mohamad T, Moughrabieh MK, Lai Z, Ager J,
van de LJ. Hepatosplenic candidiasis, a late manifestation of Soubani AO. Isolation of Aspergillus in critically ill patients:
Candida septicaemia in neutropenic patients with haematologic a potential marker of poor outcome. J Crit Care. December
malignancies. Blut. 1990;60(4):242-248. 2006;21(4):322-327.

Section05-O-ref.indd 13 1/20/2015 4:51:20 PM